Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 1;18(5):1417-1421.
doi: 10.22034/APJCP.2017.18.5.1417.

Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases

Affiliations

Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases

Berna Akinci Ozyurek et al. Asian Pac J Cancer Prev. .

Abstract

Haemogram assessment is a cheap and easy method which can be readily performed for almost all patients. Leucocyte, neutrophil and lymphocyte counts and the neutrophil to lymphocyte ratio (NLR) are markers of systemic inflammation. We here aimed to evaluate haemogram parameters of our patients with lung cancer according to the pathologic diagnosis of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Materials and Methods: The study included 386 patients diagnosed with lung cancer in our hospital between January 2006 and January 2014. A retrospective examination was made of the data from the patient records and the hospital information. NLR values were categorised into two groups: <3 and ≥3. Results: Median survival time in patients aged <65 years was 28.7 months and in those aged ≥65 years, it was 18.4 months (p<0.001). The median survival time was 20.2 months in NSCLC and 13.0 months in SCLC patients (p<0.001). In NSCLC cases with NLR<3 the median survival time (31.1 months) was longer than that of patients with NLR≥3 (18 months) (p=0.003). In SCLC patients, no relationship could be found between NLR and median survival time (p=0.408). With every 1 unit increase in lymphocyte count a 5.5% decrease in risk of periodic death ((1/0.947)x100=5.5%) was noted. Conclusion: The results of this study demonstrated that lymphocyte count, neutrophil count, Hb, Htc, and NLR are useful in determining prognosis in lung cancer (LC) patients and NLR could be more significant in determining the prognosis in NSCLC than in SCLC cases.

Keywords: Lung cancer; haemogram; neutrophil to lymphocyte ratio (NLR).

PubMed Disclaimer

Similar articles

Cited by

References

    1. Albain KS, Swann RS, Rusch VW, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer:a phase III randomised controlled trial. Lancet. 2009;374:379–86. - PMC - PubMed
    1. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer:a systemic, quantitative review. Cancer. 2001;91:2214, 21. - PubMed
    1. Cedres S, Torrejon D, Martınez A, et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol. 2012;14:864, 9. - PubMed
    1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860, 7. - PMC - PubMed
    1. Deng M, Ma X, Liang X, et al. Are pretreatment neutrophil-lymphocyte ratio and plateletlymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Oncotarget, Advance Publications. 2017 - PMC - PubMed